NCT02987361

Brief Summary

The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve upper limb motor recovery in the sub-acute phase of stroke patients. This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2016

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

December 8, 2016

Status Verified

December 1, 2016

Enrollment Period

1 month

First QC Date

August 31, 2016

Last Update Submit

December 7, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Upper Motor Score change

    before treatment, 48 hours after treatment, 4 weeks after treatment

Secondary Outcomes (3)

  • Manual Muscle Test (MMT) change

    before treatment, 48 hours after treatment, 4 weeks after treatment

  • Range of Motion (ROM) change

    before treatment, 48 hours after treatment, 4 weeks after treatment

  • Korean version Modified Bathel Index (KMBI) change

    before treatment, 48 hours after treatment, 4 weeks after treatment

Study Arms (4)

treatment group 1

EXPERIMENTAL

anodal stimulation on the lesioned primary motor cortex DC-STIMULATOR PLUS

Device: DC-STIMULATOR PLUS

treatment group 2

EXPERIMENTAL

cathodal stimulation on the non-lesioned primary motor cortex DC-STIMULATOR PLUS

Device: DC-STIMULATOR PLUS

treatment group 3

EXPERIMENTAL

dual stimulation such as anodal stimulation on the lesioned side and cathodal stimulation on the non-lesioned side DC-STIMULATOR PLUS

Device: DC-STIMULATOR PLUS

sham group

SHAM COMPARATOR

sham group

Device: DC-STIMULATOR PLUS

Interventions

2mA for 20minutes a day, 5 days per weeks, totally 2 weeks

Also known as: tDCS
sham grouptreatment group 1treatment group 2treatment group 3

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20-85
  • Unilateral Stroke patients
  • Patients who have evoked motor potentials on the first dorsal interossei muscles on hemiplegic hand
  • The patient has subscribed the informed consent

You may not qualify if:

  • Insert a metal object on the head
  • Convulsive disorders
  • History of brain diseases other than stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kim Yeon Hee

Seoul, Ilwon, 06355, South Korea

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Myoung Hwan Ko, MD, PhD

    634-18, Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk, 561-712 Republic of Korea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Min Jung YU, MANAGER

CONTACT

Myoung Hwan Ko, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 31, 2016

First Posted

December 8, 2016

Study Start

November 1, 2016

Primary Completion

December 1, 2016

Study Completion

August 1, 2018

Last Updated

December 8, 2016

Record last verified: 2016-12

Locations